Related Experiment Videos
Potential identifiability and preventability of adverse events using information systems
D W Bates1, A C O'Neil, D Boyle
1Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
Journal of the American Medical Informatics Association : JAMIA
|September 1, 1994
Summary
Computerized information systems (ISs) can identify and prevent adverse events in medical patients. Higher system sophistication, especially Level 3, significantly improves identification and prevention capabilities.
Area of Science:
- Medical Informatics
- Patient Safety
- Health Information Technology
Background:
- Adverse events in medical patients pose significant risks.
- Computerized information systems (ISs) offer potential for improving patient safety.
- Current capabilities of ISs in identifying and preventing adverse events require evaluation.
Purpose of the Study:
- To assess the effectiveness of computerized information systems (ISs) in identifying and preventing adverse events.
- To determine the impact of IS sophistication levels on adverse event detection and prevention.
- To identify key data points and system features that enhance adverse event management.
Main Methods:
- A cohort of 3,138 medical patients was analyzed, with 133 identified adverse events.
- Three hierarchical levels of IS sophistication were defined (Level 1 to Level 3).
- Two reviewers assessed the potential for event identification and prevention using IS data and event monitors.
Main Results:
- Adverse event identification rates increased with IS sophistication: 53% (Level 1), 58% (Level 2), and 89% (Level 3).
- Key identifiers included "panic" laboratory results, ICU transfers, and hospital-incurred trauma.
- Preventability rates were 5% (Level 1), 13% (Level 2), and 23% (Level 3), with algorithms and checks being most effective.
Conclusions:
- Advanced computerized information systems (ISs) significantly enhance the identification and prevention of adverse events.
- Level 3 IS sophistication, incorporating comprehensive clinical data, shows the highest potential for impact.
- Targeted interventions, such as guided-dose algorithms and drug-patient checks, are crucial for preventing identified adverse events.